Condition
Uveal Melanoma, Recurrent clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Uveal Melanoma, Recurrent clinical trials that are recruiting, at sites in 2 countries (most in United States (2), Australia (1)). By phase: Phase 1/2 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
NBM-BMX for adults with metastatic uveal melanoma — dose-finding and safety
This study will test whether taking the oral drug NBM-BMX twice daily is safe, how the body handles it, and whether it can slow or shrink tumors in adults with metastatic uveal melanoma while finding the best dose.
-
Testing ONM-501 alone and with Cemiplimab for advanced solid tumors and lymphomas
This study is testing a new treatment called ONM-501, both alone and with another drug called cemiplimab, to see if it can help people with advanced solid tumors and lymphomas who have run out of other treatment options.
Related topics
Quick answers
How many Uveal Melanoma, Recurrent clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (2 trials), Australia (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.